GordonMD Entities' Ownership in Pyxis Oncology

GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, GordonMD Long Biased GP LLC, and Craig D. Gordon have jointly filed a Schedule 13G indicating their ownership of 6.2% of the Common Stock of Pyxis Oncology, Inc. The filing, dated September 23, 2025, reports that these entities collectively own 3,834,740 shares. The shares are held by advisory clients of GordonMD Global Investments LP, with GordonMD Long Biased Master Fund LP being the only client owning more than 5% of the Common Stock. The filing is made under Rule 13d-1(c) and includes a Joint Filing Agreement and Control Person Identification as exhibits.